""Skin in the Game""19 Feb 2020 17:25
Seems to be a real concern now for some, now we have had the IND approved for SCIB1. I would be very happy for the trial to start by injecting first patients by Q3 realistacally, SCIB2 well that could be anytime, disappointed with newsflow on that from CRUK TBH, and not expecting MOD1 till Q1 2021. Hopes are very high for Avidamab and a commercial deal by Q4 2020 will be very welcome.
That is just my opinion, anything else is a bonus, any news could come at any time, but I think the BOD have a lot of skin in the game already. There could well be a new share option package for CH, dependant on Avidamab for all we know., but I feel those timelines are realistic/ I didn"t hear too much about lack of skin in the game as we rose to 8p a few times recently, as evr they tend to begin after a large sell and a red day, as they did when City & Financial sold at 3p!!!